Articles

Historically, therapies for patients with MM included high-dose dexamethasone, alkylating agents, and autologous stem cell transplantation. In the late 1990s, a new era in myeloma treatment began with the introduction of the immunomodulatory drug (IMiD) thalidomide, followed by subsequent development of the proteasome inhibitors bortezomib and carfilzomib, and the next-generation IMiDs lenalidomide and pomalidomide. Read More ›

A brief, Internet-based psychological intervention improved quality of life, reduced fatigue, and reduced distress levels in patients with newly diagnosed cancer. Read More ›

Hair loss is a well-known side effect of chemotherapy, but alopecia can also occur with endocrine therapy. Read More ›

On August 17, 2017, the FDA approved a new indication for olaparib, in tablet form, for the maintenance treatment of women with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer whose disease completely or partially responded to chemotherapy that was platinum-based, regardless of their BRCA mutation status. Read More ›

We all know that green is good if it is the vibrant color of leafy vegetables. For consumer health, leafy vegetables warrant a constant coaxing from the ranks of nutritionists, television health gurus, and medical practitioners, thanks to numerous studies showcasing the reasons why. Read More ›

Lynch syndrome is a hereditary cancer syndrome that places individuals at an increased risk for colorectal, endometrial, stomach, ovarian, urothelial, and other cancers. Read More ›

Long-term, regular use of aspirin was associated with reduced risk for death from any cause, as well as death from cancer, in a very large observational study reported at the 2017 Annual Meeting of the American Association for Cancer Research. Read More ›

Unanticipated cardiotoxicity occurs in an estimated 3.5% of patients with hematologic malignancies secondary to the use of targeted therapies. Read More ›

Trends in the adoption of electronic health records (EHRs) show increasing use of advanced functionality. More providers are now using more advanced EHRs that include electronic clinical information and computerized entry of provider orders, as well as results management and decision support. Read More ›